Full-Time

Manager – Site Planning

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior

Oxford, UK

This position is site-based, requiring full-time presence at Moderna’s site.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • BS/BA in Supply Chain, Science or Economics/Finance with 10 years’ experience.
  • 8+ years’ experience as a Production Planner within Biotech, Pharma or other related batch production manufacturing environments. DS manufacturing Site experience strongly preferred.
  • 5+ years’ experience with SAP MPS and MRP.
  • This position is site-based, requiring you to be at Moderna’s site full-time. This position is not eligible for remote work.
  • APICS/ASCM CPIM and CSCP accreditations preferred.
  • Working knowledge of site supply chain processes including demand management, S&OP, production planning, capacity planning, material planning and procurement, order fulfilment, master data and life-cycle management.
  • Demonstrated ability to lead through influence, at all levels, in a complex environment with matrix organization.
  • Demonstrated ability to collaborate across boundaries (functional and cultural) and form effective working relationships with colleagues.
  • Customer and business focused – determined to deliver successful outcomes in a cost-effective way.
  • Demonstrated change management and process management experience is preferred: demonstrated usage of data to drive process improvements.
  • Intermediate to advanced Excel skills.
Responsibilities
  • Leading site-based planning processes, including driving critical discussions with stakeholders on a weekly and monthly basis.
  • Ensuring alignment with global supply chain standards within your area of responsibility.
  • Collaborating with the Global SC Planning team to align tactical planning with site-specific requirements.
  • Overseeing short-term production, release, and supply plans to proactively address deviations from expected timelines.
  • Partnering with the warehouse operations lead and supporting the site SC lead to prioritize supply needs and ensure required Customer Service Levels (CSL).
  • Monitoring and optimizing site capacity over the tactical horizon for Drug Substance (DS), aligning with requirements from the Sales and Operations Planning (S&OP) process.
  • Supporting the development of a comprehensive and optimized production plan, addressing major risks and required decisions in monthly supply reviews.
  • Maintaining planning and master data parameters in collaboration with the master data management and global supply chain teams.
  • Measuring performance metrics such as on-time supply to plan, inventory levels, and site inventories of critical materials against targets weekly.
  • Conducting root cause analyses to identify and resolve systemic issues, ensuring consistent achievement of performance levels.
  • Coordinating with the Global Material Planning team to ensure weekly and monthly material availability.
  • Contributing to the continuous improvement of site-specific supply chain processes.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?